RSV Vaccine Effectiveness Lower in Immunocompromised Older Adults
Researchers have shown that people 60 years or older who are immunocompromised do not respond as strongly to vaccines against RSV.
Related Articles
Multiracial adults face elevated asthma prevalence
Among adults in California, those who identified as multiracial had greater lifetime and current asthma prevalences vs. the monoracial populations they shared identities with, according…
European Respiratory Society
European Respiratory Society. 36,086 likes · 245 talking about this. With members in over 100 countries, the European Respiratory Society (ERS) aims to alleviate sufferi
Proteomic Risk Score of Increased Respiratory Susceptibility: A Multicohort Study
Rationale: Accelerated decline in lung function is associated with incident chronic obstructive pulmonary disease (COPD), hospitalization, and death. However, identifying this trajectory with longi…
Toll-like Receptor 9 Inhibition Mitigates Fibroproliferative Responses in Translational Models of Pulmonary Fibrosis
Rationale: Idiopathic pulmonary fibrosis (IPF) is a fatal lung disease for which current treatment options only slow clinical progression. Previously, we identified a subset of…
Effects of Mask Change/Renewal on Adherence to Positive Airway Pressure Therapy: Analysis of a Large Telemedicine Database
Rationale: Adherence to positive airway pressure (PAP) therapy is a common and challenging issue. Although some studies have looked at the impact of initial mask…
Increased Pulmonary GM-CSF Causes Alveolar Macrophage Accumulation. Mechanistic Implications for Desquamative Interstitial Pneumonitis
Persistent pulmonary hypertension of the newborn (PPHN) is a hypoxic disorder of pulmonary vascular relaxation, mediated in part by adenylyl cyclase (AC). Neonatal pulmonary arteries…
How to protect yourself from the smoke caused by L.A. wildfires
The fires in L.A. have caused terrible air quality conditions across the county. Here are ways you can protect yourself, and your children, from the…
FDA grants priority review to oral non-small cell lung cancer drug
The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with locally advanced or metastatic non-small…
Odds for OSA drop with optimal, intermediate healthy lifestyles
The likelihood for obstructive sleep apnea went down by 74% among adults with optimal vs. insufficient healthy lifestyle behaviors, according to results published in BMC…